GlassScriptPhysician profile
Paul J Powers
NPI 1699837203
$529.16
in general payments reported to CMS, 2019-2025
10 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.25 · 2023: $146 · 2024: $56.63 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $162.62 | 2022-2025 | Exogen Ultrasound Bone Healing System, Durolane |
| Zimmer Biomet Holdings, INC. | $85.05 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Vertex Pharmaceuticals Incorporated | $61.16 | 2025 | |
| Amgen INC. | $54.39 | 2023-2024 | Evenity, Prolia |
| Horizon Therapeutics Plc | $44.29 | 2023 | Krystexxa |
| Pacira Pharmaceuticals Incorporated | $38.30 | 2023-2025 | Zilretta, Exparel, Iovera |
| Heron Therapeutics, INC. | $23.97 | 2024 | Zynrelef |
| Pylant Medical | $22.23 | 2023 | |
| Organogenesis INC. | $20.61 | 2023 | Puraply |
| Solventum Corporation | $16.54 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.